EVALUATE THE EFFICACY AND SAFETY OF SAXAGLIPTIN IN COMBINATION WITH METFORMIN IR COMPARED TO SAXAGLIPTIN MONOTHERAPY AND TO METFORMIN IR MONOTHERAPY IN DRUG NAIVE CHINESE SUBJECTS WITH TYPE 2 DIABETES WHO HAVE INADEQUATE GLYCAEMIC CONTROL: